Wu, A.T.H.; Huang, H.-S.; Wen, Y.-T.; Lawal, B.; Mokgautsi, N.; Huynh, T.-T.; Hsiao, M.; Wei, L.
A Preclinical Investigation of GBM-N019 as a Potential Inhibitor of Glioblastoma via Exosomal mTOR/CDK6/STAT3 Signaling. Cells 2021, 10, 2391.
https://doi.org/10.3390/cells10092391
AMA Style
Wu ATH, Huang H-S, Wen Y-T, Lawal B, Mokgautsi N, Huynh T-T, Hsiao M, Wei L.
A Preclinical Investigation of GBM-N019 as a Potential Inhibitor of Glioblastoma via Exosomal mTOR/CDK6/STAT3 Signaling. Cells. 2021; 10(9):2391.
https://doi.org/10.3390/cells10092391
Chicago/Turabian Style
Wu, Alexander T. H., Hsu-Shan Huang, Ya-Ting Wen, Bashir Lawal, Ntlotlang Mokgautsi, Thanh-Tuan Huynh, Michael Hsiao, and Li Wei.
2021. "A Preclinical Investigation of GBM-N019 as a Potential Inhibitor of Glioblastoma via Exosomal mTOR/CDK6/STAT3 Signaling" Cells 10, no. 9: 2391.
https://doi.org/10.3390/cells10092391
APA Style
Wu, A. T. H., Huang, H. -S., Wen, Y. -T., Lawal, B., Mokgautsi, N., Huynh, T. -T., Hsiao, M., & Wei, L.
(2021). A Preclinical Investigation of GBM-N019 as a Potential Inhibitor of Glioblastoma via Exosomal mTOR/CDK6/STAT3 Signaling. Cells, 10(9), 2391.
https://doi.org/10.3390/cells10092391